Biomarkers in Clinical Trials

Venue: Central London

Location: Central London, United Kingdom

Event Date/Time: Sep 19, 2011 End Date/Time: Sep 20, 2011
Early Registration Date: May 31, 2011
Report as Spam


SMi proudly presents their 3rd annual conference on...
Biomarkers in Clinical Trials
19th and 20th September 2011, Central London, UK

Book by 31st May & Save £300
Register Online:

What our previous delegates had to say:

“Good relevant content, very well chaired, good presentations” Group Leader, UCB
"Great mix of Pharma and Non-Pharma" Biomarker Logistics Manager, Merck Serono

Sponsored By:
Definiens and RBM

To be featured on this year’s brochure and for all sponsorships & exhibition opportunities:
Contact Alia Malick on tel +44 (0)20 7827 6168 or email:
Clinical trials are a costly necessity and when the decrease in drug discovery success rate is taken into account, finding new routes to streamlining them is essential in an era of mandatory efficiency. Expediting drugs while decreasing expense, lies at the heart of the rationale behind using biomarkers. Optimising clinical trials by virtue of biomarkers at R&D can improve decision making, allowing for later stage failure rates to be reduced.
As a result biomarkers have now gained significant attention in the R&D process, and are seen as an emerging but lucrative segment that is opening up new development opportunities, and attracting much commercial interest.
The global biomarker market is estimated to be £12.7 billion by 2014, and driven by the high demand for the biomarkers in the field of drug discovery. In addition the increasing use of biomarkers in clinical services is boosting the overall biomarker service provider market.

This year's Biomarkers in Clinical Trials conference will equip delegates with an understanding of:
1. Translational Research
2. Imaging Biomarkers and new platforms
3. Tratification Biomarkers and Validation
4. Reviewing Clinical Studies and Exploring Market Access.

Benefits of attending:
• Develop an understanding of the commercial implications of biomarkers in clinical trials
• Gain knowledge about how to successfully use biomarkers
• Learn from a vastly experienced speaker line-up
• Collect valuable CPD points through attendance

>>For further information please visit:

Hear keynote addresses from:
• Mark Fidock, Senior Principle Scientist, Biomarkers and Translational Biology, Pfizer
• Russell Petty, Clinical Senior Lecturer in Medical Oncology, University of Aberdeen
• Roger Luo, Director, Translational Medicine, Johnson & Johnson Ortho Biotech
• Sterghios Moschos, Principal Scientist, Pfizer
• Fred Zheng, Clinical Biomarker Group, Oncology Clinical Development, AstraZeneca
• Theresa Zhang, Research Fellow, Merck
• Vincent Haddad, Biostatistician Manager, Amgen
• Taoufik Ouatas, Translational Science, Clinical Pharmacology and Exploratory Medicine Leader, Astellas

>> For our full speaker line-up visit:

Plus an interactive post conference workshop on:
The Role of Biomarkers in Clinical Trials
Host by: Granzer Regulatory Consulting
21st September 2011, 8.30am - 1.30pm

To reserve your place for this conference and workshop visit:
For more information, please visit